TY - JOUR AU - Li, Mingshu AU - Chen, Jun AU - Fang, Zhixiong AU - Li, Yi AU - Lin, Qian PY - 2019 DA - 2019/03/14 TI - Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis JO - Virology Journal SP - 34 VL - 16 IS - 1 AB - Whether sofosbuvir is suitable for hepatitis C virus (HCV) infected patients with severe renal impairment is inconclusive. This systematic review aims to evaluate the safety and effectiveness of SOF-based regimen in the setting of stage 4 and 5 chronic kidney disease (CKD). SN - 1743-422X UR - https://doi.org/10.1186/s12985-019-1140-x DO - 10.1186/s12985-019-1140-x ID - Li2019 ER -